CD274 and small cell lung carcinoma: The exceptional clinical activity of T-cell engagers in patients with SCLC versus other solid tumors might relate to the frequent suppression of antigen processing and presentation machinery in SCLC – a mechanism of immune escape associated with resistance to PD-(L)1-directed immunotherapy but bypassed by T-cell engagers (94).